Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Bicalutamide|DRUG: Aromatase Inhibitor
Sponsor: Xu fei
Collaborators: Sun Yat-sen University